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Protein abnormalities in cells are the cause of major pathologies,
and a number of adaptive responses have evolved to relieve the
toxicity of misfolded polypeptides. To trigger these responses,
cells must detect the buildup of aberrant proteins which often
associate with proteasome failure, but the sensing mechanism is
poorly understood. Here we demonstrate that this mechanism
involves the heat shock protein 70–Bcl-2–associated athanogene 3
(Hsp70–Bag3) complex, which upon proteasome suppression re-
sponds to the accumulation of defective ribosomal products, pref-
erentially recognizing the stalled polypeptides. Components of the
ribosome quality control system LTN1 and VCP and the ribosome-
associated chaperone NAC are necessary for the interaction of
these species with the Hsp70–Bag3 complex. This complex regu-
lates important signaling pathways, including the Hippo pathway
effectors LATS1/2 and the p38 and JNK stress kinases. Further-
more, under proteotoxic stress Hsp70–Bag3–LATS1/2 signaling
regulates protein aggregation. We established that the regulated
step was the emergence and growth of abnormal protein oligo-
mers containing only a few molecules, indicating that aggregation
is regulated at very early stages. The Hsp70–Bag3 complex there-
fore functions as an important signaling node that senses proteo-
toxicity and triggers multiple pathways that control cell physiology,
including activation of protein aggregation.
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In aging and in many protein conformation disorders organismsexperience suppression or failure of the ubiquitin–proteasome
system (UPS), which causes a major buildup of abnormal pro-
teins. Such abnormal species increase the load on the protein deg-
radation and folding machineries. They can form toxic aggregates
and further exacerbate aging and facilitate age-related protein
conformation disorders (1). In response to proteasome suppression,
cells activate pathways that can relieve the proteotoxic stress, in-
cluding aggresome formation and autophagy. Other pathways acti-
vated under these conditions can trigger programmed cell death or
regulate various aspects of cell physiology, e.g., the stress kinases JNK
and p38 (2), the heat shock response (3), the unfolded protein re-
sponse (4), or transcription factor NRF2 (5). How mammalian cells
sense the proteasome’s failure to modulate many of these pathways is
not well understood. Such knowledge would significantly enhance our
understanding of the biology of stress response and the molecular
basis of many protein conformation disorders. Here we hypothesized
that the proteotoxic stress-sensing mechanism involves a complex of
the heat shock protein 70 (Hsp70) and a cochaperone BCL-2–
associated athanogene 3 (Bag3) (the HB complex).
Our prior work has shown that the HB complex controls
several cancer-related signaling pathways (6, 7). However, in-
volvement of this complex in the regulation of other pathways
has not been explored. Bag3 is a multidomain protein that in-
teracts with Hsp70 family members through a specialized Bag
domain and with small heat shock protein (sHSP) family mem-
bers through a site in its so-called “M-domain” (8). Bag3 has a
PXXP motif and a WW domain responsible for its interaction
with a number of signaling factors. The domain structure of
Bag3 suggests that it can serve as a scaffold that links Hsp70 with
multiple signaling pathways.
Considering that the HB complex has the capacity to interact with
abnormal protein molecules (9, 10), we hypothesized that this
module could act as a sensor of protein abnormalities in the cell and
transduce signals to downstream pathways. Here we describe three
pathways (i.e., JNK, p38, and Lats1/2) which are regulated under
proteotoxic conditions via interactions with the HB complex. We
found that upon proteasome failure this complex primarily senses
the buildup of defective ribosomal products (DRiPs) and that
components of the ribosome-associated quality control (RQC) sys-
tem and a ribosome-associated chaperone, nascent polypeptide-
associated complex (NAC), play an important role in the sensing
process. Finally, via modulation of Lats1/2 activity under these
conditions, the HB complex regulates the early stages of the aggre-
gation of abnormal proteins before their transport to the aggresome.
Results
The Hsp70–Bag3 Complex Mediates the Activation of Signaling Pathways
in Response to Proteasome Inhibition. Multiple regulatory systems
respond to proteasome failure and other proteotoxic stresses, but how
these stimuli are sensed remains poorly understood. We hypothe-
sized that the Hsp70–Bag3 module responds to the accumulation of
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abnormal polypeptides by triggering various signaling events. To test
the idea that the HB complex can regulate numerous signaling re-
sponses to proteotoxic stress, we assessed the effects of proteasome
inhibition on the spectrum of Bag3 partners. HeLa cells were
transfected with plasmids expressing His-tagged Bag3 or its ΔC de-
letion mutant that lacks the Bag-domain essential for interaction
with Hsp70. After treatment with the proteasome inhibitor MG132,
Bag3 was isolated together with associated proteins using cobalt af-
finity resin (SI Appendix, Fig. S1A), and the complexes were analyzed
by mass spectrometry. An isolate from cells transfected with an
empty vector was used as a negative control. In agreement with a
previous report (11), levels of both major Hsp70 family members
were dramatically reduced in ΔC pull-downs compared with full-
length Bag3 (Dataset S1), indicating the specificity and quantifica-
tion reliability of the analysis. Overall, Dataset S1 demonstrates that
Bag3 associates with a large number of cellular proteins, including
those involved in signaling. Understandably, some proteins in Dataset
S1 could be associated with Bag3 indirectly as a part of multiprotein
complexes. Notably, deletion of the Hsp70-binding domain prevented
many of these interactions, suggesting that these Bag3 partners as-
sociate with the HB complex as a whole. Importantly, inhibition of
proteasome activity significantly affected the interactions of Bag3
with many partners, including several regulatory proteins (Dataset
S1), suggesting the involvement of HB complex in various regula-
tory processes triggered by proteotoxic challenges.
Among the signaling proteins that associate with Bag3 in an
Hsp70-dependent way, we detected mitogen-activated protein kinase
p38 (Dataset S1). Since proteasome inhibitors can stimulate both
p38 and homologous JNK kinases (2), we reasoned that JNK may
also associate with Bag3 but escape detection by mass spectrometry,
which could happen for multiple reasons, e.g., poor ionization of
peptides. Indeed, we detected JNK in the Bag3 pull-downs by im-
munoblotting (SI Appendix, Fig. S1B). As with p38, the association of
Bag3 and JNK was reduced by the deletion of the Bag domain,
suggesting that Hsp70 affects the interaction between Bag3 and JNK.
To test whether Bag3 mediates p38 and JNK responses upon pro-
teasome inhibition, we depleted Bag3 in MCF10A cells and found
that activation of these kinases by MG132 treatment indeed was
reduced significantly in the depleted cells (Fig. 1A). To examine the
role of Hsp70 in this signaling, we depleted HspA8, the major con-
stitutively expressed Hsp70 family member, and simultaneously
depleted the heat shock transcription factor Hsf1 to avoid a com-
pensatory up-regulation of the inducible Hsp70 isoform HspA1 (SI
Appendix, Fig. S1C) (12). Indeed, similar to the depletion of Bag3, the
reduction of HspA8 levels suppressed the activation of p38 and JNK
by proteasome inhibitors (SI Appendix, Fig. S1D). These data
therefore indicate that the HB complex plays a critical role in the
regulation of stress kinases in response to proteasome inhibition.
Several signaling factors, including LATS1/2, a component of the
Hippo pathway, had been reported to interact with Bag3 (13). First,
we confirmed the association of endogenous LATS1 with Bag3 and
analyzed how deletions of various functional Bag3 domains affect
its association with LATS1. As described above, we pulled down
His-tagged Bag3 constructs, including WT and deletion mutants,
and analyzed the isolated complexes by immunoblotting. While
LATS1 was found in association with WT Bag3, none of this pro-
tein was pulled down with the ΔWW deletion construct, indicating,
in line with the previous report (13), that this domain is critical for
the interaction. Importantly, the ΔC deletion also reduced the as-
sociation of Bag3 with LATS1, suggesting that LATS1 is prefer-
entially recruited to the HB complex rather than to Bag3 alone. In
contrast, deletion of the sHSP-binding domain (ΔM) of Bag3 did
not significantly affect its association with LATS1 (Fig. 1B). These
data confirm that association between Hsp70 and Bag3 plays a role
in the recruitment of LATS1.
We hypothesized that, as with JNK and p38, LATS1/2 re-
sponses could be triggered by a buildup of abnormal proteins and
that the triggering of these responses is mediated by the HB
complex. First, we tested whether proteasome inhibition affects
LATS1/2 activity. We incubated MCF10A cells with MG132 and
assessed LATS1/2 activity by measuring the phosphorylation
levels of one of its substrates, the transcriptional regulator YAP.
Indeed, YAP phosphorylation by LATS1/2 was significantly
suppressed in response to the proteasome inhibitor (Fig. 1C),
indicating activation of the Hippo pathway under these condi-
tions. Consistent with this activation, we observed that expres-
sion of the YAP target gene CTGF was up-regulated upon
exposure to MG132 (SI Appendix, Fig. S1E).
To test if the LATS1/2 response is mediated by the HB
complex, we measured the effects of MG132 treatment in cells
depleted of either of the two elements of the complex. Depletion
of Bag3 reversed the suppression of LATS1/2 activity upon
proteasome inhibition (Fig. 1D). Similarly, depletion of HspA8
(against the background of Hsf1 depletion) blocked the regula-
tion of LATS1/2 by proteasome inhibitors (Fig. 1E), suggesting
that the HB complex is critical for this signaling process.
To investigate further the role of the Hsp70–Bag3 complex in
the regulation of LATS1/2, we depleted endogenous Bag3 with
siRNA and replaced it with siRNA-resistant forms of either WT
Bag3 or a construct missing the Hsp70-interacting Bag domain
(ΔC) (SI Appendix, Fig. S1F). Expression of WT Bag3 completely
reversed the effects of Bag3 siRNA on LATS1/2 suppression (Fig.
1F and SI Appendix, Fig. S1G). In contrast, the ΔC mutant could
not reverse the effects of MG132 on LATS1/2 activity (Fig. 1F).
Furthermore, acting as a dominant-negative mutant, it partially
inhibited the effects of MG132 on LATS1/2 activity even in the
control cells with unaltered levels of endogenous Bag3. In line with
this finding, YM1, a small molecule that targets Hsp70 family
members and disrupts their interaction with Bag3 (6), completely
reversed the effect of MG132 on LATS1/2 activity (Fig. 2A, last
lane). These observations indicate that the interaction between
Bag3 and Hsp70 plays a critical role in the regulation of LATS1/
2 upon proteasome inhibition. Because of the WW domain-
dependent interaction of Bag3 with LATS1/2, the effects of the
HB module on LATS1/2 activity are likely to be direct, although we
cannot exclude the possibility of the indirect effects. Together, these
data indicate that the HB complex monitors the effectiveness of pro-
tein degradation in a cell to modulate a number of signaling pathways.
Sensing of DRiPs by the HB Complex. We examined the signaling
events upstream of the HB complex. Upon proteasome in-
hibition, the HB complex could sense either the accumulation of
a specific, short-lived regulatory protein(s) or a general buildup
of abnormal polypeptides. To assess these possibilities, we took
advantage of a recently described effect of mild inhibition of
translation elongation on the quality of ribosome output. We and
others have shown that at concentrations that only mildly sup-
press protein synthesis, these inhibitors significantly improve
cotranslational folding, thus decreasing the fraction of aberrant
polypeptides in the pool of newly generated proteins (14–16).
We added 150 nM of the translation inhibitor emetine, which
decreases the ribosomal output by about 50% (17), and found
that under these conditions the effects of MG132 on the down-
regulation of LATS1/2 activity were almost completely sup-
pressed (Fig. 2B). We confirmed this finding with another
inhibitor of translation elongation, cycloheximide, at concentra-
tions that inhibited translation by less than 50% (SI Appendix, Fig.
S2A). These experiments indicate that LATS1/2 suppression by
proteasome inhibition depends on the de novo generation of
polypeptides. The fact that the response is blocked by improved
folding of newly synthesized polypeptides suggests that this sup-
pression is triggered by the buildup of aberrant proteins released
from ribosomes, although the possibility remains that the mild
inhibition of translation was sufficient to suppress the buildup of a
putative short-lived regulator of the LATS1/2 response. To further
test the role of abnormal newly synthesized polypeptides in the
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regulation of LATS1/2, we employed the proline analog L-
Azetidine-2-carboxylic acid (AZC), which incorporates into trans-
lated polypeptides and prevents their folding. Accordingly, in-
corporation of AZC would have opposite effects on the levels of
the two possible triggers of regulation: The generation of any
new functional protein, including a putative short-lived regula-
tor, would be reduced, while the levels of abnormal polypeptides
would increase. In fact, AZC significantly enhanced the effects of
MG132 on LATS1/2 activity (Fig. 2A), indicating that a buildup of
aberrant proteins triggers the response.
To address the mechanism of detecting DRiPs, we first tested
whether the entire HB-LATS complex can associate with them.
Notably, it was reported that Bag3 can bind newly synthesized
unstable proteins in an Hsp70-dependent manner (18). We
confirmed this observation in our model by showing that deletion
of the Hsp70-binding Bag domain reduces the association of
Bag3 with ubiquitinated proteins, most of which represent newly
synthesized polypeptides (SI Appendix, Fig. S2B) (17). To further
address the association of the HB complex with DRiPs, we ra-
diolabeled newly synthesized proteins with S35-methionine and
S35-cysteine for 10 min. Under these conditions, short-lived
polypeptides, including DRiPs, form a large fraction of all la-
beled proteins. We analyzed their association with His-tagged
Bag3 pulled down from HeLa cells as described above. Beside
the major band of Bag3, the pull-down samples contained a
number of bands that appear to represent DRiPs (SI Appendix,
Fig. S2C). Indeed, quantification of the gel showed that the
fraction of the labeled species associated with Bag3 decreased
during a 1 h chase, while in the cells labeled in the presence of
MG132 the association increased (Fig. 2C and SI Appendix).
To test whether LATS1 can associate with DRiPs as a part of
the HB complex, we pulled down ubiquitinated proteins from
Fig. 1. The HB complex mediates LATS1/2 suppression in response to proteasome inhibition. The antibodies for immunoblots are indicated on the right. (A)
Bag3 depletion reverses the effects of proteasome inhibition on JNK and p38 activity. Control MCF10A cells and MCF10A cells depleted of Bag3 were treated with
MG132 under the indicated conditions. Here and throughout the figures, the results of immunoblotting of total cellular lysates were independently reproduced at
least three times. (B) The effects of the deletion of various functional domains in Bag3 on its association with LATS1. HeLa cells were transfected with plasmids
encoding His-tagged full-length Bag3, with Bag3 deletion mutants, or with empty plasmid (vector, V). Here and throughout this work HeLa cells were utilized
because, unlike MCF10A cells, they could be efficiently transfected with a plasmid DNA. On the next day the cells were treated for 75 min with 5 μMMG132 or were
left untreated. Then the cells were incubated for 10 min with 1.2% formaldehyde, and His-tagged constructs were isolated using cobalt affinity resin. To calculate
relative amounts of LATS1 associated with each His-tagged construct, the quantified LATS1 signal in each lane was normalized by a FLAG signal representing the
amount of pulled-down Bag3 in the same sample. No detectable signal was seen in the isolate from the cells transfected with empty vector (V). The results of this pull-
down are typical of three independent experiments. ΔC, mutant with a deleted C terminus containing the Bag domain critical for interaction with Hsp70; ΔM,
mutant with a deleted M-domain; ΔP, mutant with a deleted PxxP motif;ΔWW,mutant with a deletedWWdomain; WT, full-length Bag3. (C) Proteasome inhibition
leads to the suppression of LATS1/2 activity as monitored by phosphorylation of YAP. MCF10A cells were incubated for 3.5 h with the indicated concentrations of
MG132. (D) Bag3 depletion reduces the effects of proteasome inhibition on LATS1/2 activity. Control MCF10A cells and cells depleted of Bag3 were treated with
MG132 under the indicated conditions. Quantification (expressed in relative units) of the phospho-YAP signal normalized by total YAP in the same samples is shown
for each of the series. (E) Hsp70 depletion blocks the effects of proteasome inhibition on LATS1/2 activity. MCF10A cells were infected with HSF1 shRNA, briefly
selected, and 3 d after the infection were transfected with either HspA8 or control siRNA. Two days later the cells were treated with MG132. Quantification
(expressed in relative units) of the phospho-YAP signal normalized by total YAP in the same samples is shown for each of the series. (F) The Bag domain of Bag3 is
critical for the regulation of LATS1/2 by proteasome inhibition. MCF10A cells were infected with retroviruses encoding full-length Bag3 (WT) or its ΔC-truncated form
(both with mutations making them resistant to the Bag3 siRNA used in this experiment) or with an empty vector. After selection, the cells were transfected with
either Bag3 (Lower), or control (Upper) siRNA and 2 d later were treated for 3.5 h with 0.6 μMMG132. Quantification (expressed in relative units) of the phospho-YAP
signal normalized by total YAP signal in the same samples is shown for each of the series. Results of an analogous experiment are shown in SI Appendix, Fig. S1G.
Meriin et al. PNAS | vol. 115 | no. 30 | E7045
BI
O
CH
EM
IS
TR
Y
lysates of MCF10A cells and assessed the amounts of associated
Hsp70 and LATS1 (we could not conclusively assess Bag3 in
these pull-downs because of significant nonspecific interactions).
Amounts of copurified LATS1, as well as Hsp70, increased upon
proteasome inhibition, and this effect was reversed upon mild in-
hibition of translation by emetine (Fig. 2C). Importantly, the addition
of YM1 (Fig. 2C), which blocks the Hsp70–Bag3 interaction, strongly
reduced the amounts of LATS1 associated with DRiPs, suggesting
that the association depends on the HB complex.
Detection of Stalled Ribosomal Polypeptides by the HB Complex. A
subset of DRiPs formed by stalled polypeptides remains bound
to the large ribosome subunit and requires special RQC ma-
chinery, including the ubiquitin ligase LTN1, for dissociation and
subsequent degradation by a proteasome (19). We sought to
investigate whether this subset of DRiPs plays a role in the
suppression of LATS1/2 activity upon proteasome inhibition in the
absence of additional protein-damaging conditions, e.g., AZC.
If stalled polypeptides represent a sizable fraction of the
DRiPs involved in this signaling, the sensing of proteasome in-
hibition may be affected by the depletion of LTN1. In fact, the
inhibitory effects of MG132 on LATS1/2 were almost completely
blocked in cells depleted of LTN1 (Fig. 3A). A similar outcome
was observed upon depletion of VCP (SI Appendix, Fig. S3A),
another factor involved in the release of stalled polypeptides
from the large ribosomal subunit (19). These data suggest that in
the absence of additional protein-damaging challenges, e.g., ex-
posure to AZC, the stalled polypeptides play a major role in
sensing the proteasome inhibition. Moreover, since LTN1 and
VCP are necessary for the release of these species from the large
ribosome subunit, these data further suggest that the DRiPs are
detected by the HB complex after their release from the ribo-
somes. However, it should be cautiously noted that VCP affects
multiple processes in protein homeostasis, and therefore its ef-
fects on LATS1/2 regulation may be indirect.
To assess direct interactions of these species with the HB
complex, we generated a model of nonstop polypeptide, GFP-
NS, similar to one used with yeast (20). As with other stalled
polypeptides, expression of GFP-NS was low, and depletion of
LTN1 or inhibition of the proteasome resulted in increased
levels of this polypeptide (Fig. 3B). Nonetheless, even under
these conditions, levels of GFP-NS were significantly lower than
levels of normal GFP (Fig. 3B), most likely due to the rapid
degradation of mRNA. At these levels we were unable to detect
GFP-NS in Bag3 pull-downs.
To test if Bag3 associates with the model stalled polypeptide
released from ribosome, we employed a Duolink proximity li-
gation assay (PLA). We cotransfected HeLa cells with plasmids
encoding GFP-NS and FLAG-Bag3, treated them with MG132,
and fixed them with formaldehyde. The cells were incubated with
anti-GFP and anti-FLAG antibodies raised in rabbit and mouse,
respectively. The Duolink PLA allows microscopic detection of
these two antibodies when they bind to the antigens in close
proximity. No signal was detected in the cells transfected with
only one of the plasmids (SI Appendix, Fig. S3B). Similarly, as-
sociation between GFP-NS and Bag3 was almost undetectable in
naive cells (Fig. 3C). However, upon incubation with MG132 the
association became evident (Fig. 3C). Notably, depletion of
LTN1 significantly reduced the association between Bag3 and
GFP-NS (Fig. 3C), even though the cellular levels of the latter
were increased by the depletion (Fig. 3B).
To better quantify association between GFP-NS and Bag3, we
developed a modified proximity ligation protocol based on the
ActivSignal, Inc. approach, which allowed ultrasensitive de-
tection of a complex by qPCR. We cotransfected HeLa cells with
plasmids encoding GFP-NS and FLAG-Bag3, treated the cells
on a 96-well plate with MG132, fixed them, and incubated them
with antibodies against GFP and FLAG. Then cells were treated
with secondary antibodies against FLAG (murine) and GFP
(leporine) tagged with distinctive oligonucleotides. These oligo-
nucleotides could be ligated via a special linker only when they
were brought into proximity in a protein complex. We analyzed
the ligation products by qPCR. The experiment confirmed that
incubation with MG132 results in an association between GFP-
NS and Bag3 (Fig. 3D). With this approach, we also confirmed
that the association between GFP-NS and Bag3 depends on
LTN1 (Fig. 3D). The finding that LTN1 is necessary both for the
association of the model stalled polypeptide with the HB com-
plex and for downstream signaling (Fig. 3A) suggests that ubiq-
uitination of stalled polypeptides and most probably their
subsequent dissociation from the large ribosomal subunit are
important for binding to the HB complex.
NAC Is Involved in Sensing of DRiPs. Since the HB complex appears
to detect defective polypeptides soon after their release from
ribosomes, ribosome-associated chaperones that interact with
nascent polypeptides may also play a role in the sensing mech-
anism. The chaperone complex NAC, composed of NACA and
NACB, interacts with emerging polypeptides and facilitates their
cotranslational folding. We tested if NAC is involved in the
sorting of GFP-NS onto the HB complex. Indeed, we found that
depletion of NACA significantly reduced the association of
GFP-NS with Bag3 when monitored using the PLAs (Fig. 3 C
Fig. 2. DRiPs interact with the HB complex to activate the response to
proteasome failure. (A) Incubation with the proline analog AZC enhances
the effects of proteasome inhibition. MCF10A cells were left untreated or
were incubated for 3 h with the indicated concentrations of MG132 alone or
combined with 2.5 mM AZC. YM1, an inhibitor of the HB complex, reverses
the effects of proteasome inhibition on LATS1/2 activity. Cells were pre-
incubated with YM1 for 3 h and were incubated with 5 μMMG132 combined
with 5 μM YM1. (B) Slowing down translation lessens the effects of pro-
teasome inhibition on the suppression of LATS1/2. MCF10A cells were left
untreated or were incubated for 3 h with 1 μM MG132 alone or combined
with 0.15 μM emetine. Results of an analogous experiment with the addition
of cycloheximide are shown in SI Appendix, Fig. S2A. (C) The effects of pro-
teasome inhibition, inhibition of translation, and disruption of the HB complex
on the association of Hsp70 and LATS1 with ubiquitinated species. MCF10A
cells were incubated for 2 h with the indicated combinations of 2.5 μMMG132,
0.5 μM emetine, or 10 μM YM1. All cells incubated with YM1 were pre-
incubated for 1.5 h. After the treatments, cells were incubated for 10 min with
1.2% formaldehyde to cross-link protein complexes. Ubiquitinated species
were isolated from the cell lysates and analyzed by immunoblotting. To
measure Hsp70, we used a mixture of antibodies against HspA1 and HspA8.
Typical results of two independent experiments are shown.
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and D). Furthermore, depletion of either NACA or NACB
strongly reduced the effect of MG132 on LATS1/2 activity (Fig.
3A and SI Appendix, Fig. S3A). In addition to NAC, another
ribosome-associated chaperone complex, RAC, also binds to a
subset of nascent polypeptides and promotes their folding.
Studies in yeast indicated that RAC facilitates the folding of
about 80% of the ribosomal products, and only 20% involve
NAC (21). Therefore, we tested whether RAC also has a role in
the function of the HB complex. Unlike depletion of NAC
components, depletion of DNAJC2 (ZUO1), the integral com-
ponent of the RAC complex, did not affect the suppression of
LATS1/2 upon proteasome inhibition (Fig. 3D). These data
suggest that NAC is involved in generating the signal transmitted
via the HB complex upon proteasome inhibition.
The Hsp70–Bag3 Module Activates Aggresome Formation in Response
to Proteasome Inhibition. Proteasome inhibition can trigger
aggresome formation (22), and here we sought to understand the
role of the HB complex in this protective response. The Hsp70–
Bag3 module has been implicated in aggresome formation (23,
24). The main paradigm proposed in prior publications was that
Hsp70 physically binds to aggregated proteins, while Bag3 links
this complex with the dynein motor complex, either directly or
via 14-3-3 proteins (25, 26), for further transport to the aggre-
some. On the other hand, we previously reported that the
aggresome response is sensitive to a partial inhibition of trans-
lation and can be stimulated by amino acid analogs (for the
proline analog AZC, see SI Appendix, Fig. S4A), suggesting that
sensing of DRiPs can play a role in aggresome formation (17).
Accordingly, here we hypothesized that the HB complex may
modulate signaling that triggers aggresome formation.
To monitor aggresome formation, we utilized the GFP-tagged
synphilin 1 reporter (Syn-GFP) (27) expressed in MCF10A cells.
In this cell line the aggresome response is very sensitive to pro-
teasome inhibition, and we used submicromolar concentrations
of MG132 to trigger the response. In line with previous reports,
aggresome formation was both Bag3- and Hsp70-dependent
(Fig. 4 A and B and SI Appendix, Fig. S4B). Moreover, the ad-
dition of YM1, which disrupts the HB complex, strongly sup-
pressed aggresome formation (Fig. 4C), indicating the HB
complex has a role in aggresome triggering. Furthermore, while
Bag3 overexpression did not trigger aggresome formation on its
own, it strongly accelerated this process upon proteasome in-
hibition (Fig. 4D). In contrast, the ΔC mutant missing the Bag
domain reproducibly demonstrated an inhibitory effect (Fig. 4D).
We tested whether the factors that promote the release of
DRiPs from ribosome are required for aggresome formation.
Indeed, depletion of either LTN1 or VCP significantly reduced
this response (Fig. 4E). Furthermore, in line with the role sug-
gested above for NAC in sensing DRiPs, knocking down either
Fig. 3. Stalled proteins interact with and regulate the HB complex. (A) Effects of depletion of LTN1, NACA, or DNAJC2 (ZUO1) on the suppression of LATS1/2 upon
proteasome inhibition. MCF10A cells with the indicated depletions were incubated for the indicated times with 3 μM MG132, and the lysates were analyzed by
immunoblot. (B) Effects of proteasome inhibition and depletion of LTN1 or NACA on levels of GFP-NS. One day after siRNA transfection, HeLa cells were transfected
with plasmids encoding either GFP-NS orWT EGFP (this plasmid was 10-fold diluted with an empty vector). Indicated samples were treated for 4 h with 5 μMMG132.
(C) The effects of LTN1 or NACA depletion on the association of GFP-NS with the HB complex were assessed by the Duolink assay. HeLa cells transfected for 1 d with
one of the indicated siRNAs were transfected with a mixture of plasmids encoding GFP-NS and FLAG-Bag3 (3:1) and 1 d later were treated with MG132 or were left
untreated. The cells transfected with only the GFP-NS–encoding plasmid or only the FLAG-Bag3–encoding plasmid were used as negative controls and did not
produce any measurable signal. The cells grown on a glass-bottomed plate were treated according to the Duolink protocol with anti-GFP and anti-FLAG antibodies.
Images of the Duolink signal and of DAPI nuclear staining were taken from at least 10 randomly chosen images with a fluorescence microscope with a 20× objective.
Duolink images were quantified using NIH ImageJ software, and the data were normalized by the total number of cells in all fields chosen for each sample. The
error bars represent the SD. For images of cells, see SI Appendix, Fig. S3. (D) Effects of LTN1 or NACA depletion on the association of GFP-NS with the HB complex
assessed by the modified ActivSignal protocol. The cells were grown and treated as in Fig. 3B, but here the cells were plated on a plastic 96-well plate for incubation
with MG132 and for a following protein–protein interaction assay (Materials and Methods). The qPCR results are presented. The results for a signal produced with
the pair of anti-GFP and anti-FLAG antibodies (reflecting the amount of GFP-NS associated with FLAG-Bag3) were normalized by a signal produced with the pair of
anti-Bag3 and anti-FLAG antibodies (reflecting the relative amount of FLAG-Bag3) for the same cells. The signals generated from the cells transfected only with a
vector were used as a baseline. The error bars represent the SD. For the effect of LTN1 depletion (compared with control), P < 10−6; for NACA, P < 10−5.
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NACA or NACB dramatically reduced aggresome formation. In
contrast, depletion of DNAJC2, an integral component of RAC,
had no effect on the aggresome (Fig. 4E), further demonstrating
the specificity of NAC in cellular responses to the buildup of
DRiPs. These data strongly suggest that the release of DRiPs
and their detection by the HB complex are required for the in-
duction of aggresome formation.
To test whether the discovered HB-dependent regulation of
LATS1/2 is relevant to the aggresome response, we depleted
both LATS1 and LATS2 from MCF10A cells using a mixture of
corresponding siRNAs. Even though LATS1/2 depletion in naive
cells did not result in significant aggresome formation, it dra-
matically enhanced the process upon exposure to low concen-
trations of MG132. In fact, after 2.5 h of incubation with 30 nM
MG132, we could detect only a few aggresomes in control
MCF10A cells, while more than a third of the LATS1/2-depleted
cells developed aggresomes (Fig. 4F). Similarly, in HeLa cells the
aggresome response to 1 μMMG132 was negligible, but depletion
Fig. 4. The HB complex and its partners control aggresome formation. In all experiments cells were fixed with formaldehyde, and the fraction of cells with an
aggresome was counted under a fluorescence microscope; in all experiments less than 5% of naive cells formed an aggresome. Error bars on the graphs
depicting aggresome formation represent SEs. (A) Bag3 depletion suppresses aggresome formation. MCF10A cells stably expressing Syn-GFP with the in-
dicated depletions were treated with MG132 under the indicated conditions. (B) Hsp70 depletion suppresses aggresome formation. MCF10A cells stably
expressing Syn-GFP were infected with HSF1 shRNA and were briefly selected and transfected with either HspA8 or control siRNA. Two days later the cells
were treated for 3.5 h with 45 nM MG132. (C) Blocking the Hsp70–Bag3 interaction by the small molecule YM1 suppresses aggresome formation. MCF10A
cells stably expressing Syn-GFP were treated for 4.5 h with 100 nM MG132 with or without the addition of 5 μM YM1 or were left untreated. YM1 was added
1.5 h before the addition of MG132. (D) The effects of Bag3 on the aggresome require an intact Bag domain. HeLa cells stably expressing Syn-GFP and
transfected with plasmids encoding full-length Bag3 (WT), with its ΔC deletion mutant (ΔC), or with empty vector were treated for 5 h with 2 μMMG132. The
fraction of cells with an aggresome was counted only among the transfected cells. (E) The effects of ribosome-associated factors involved in handling DRiPs on
aggresome formation. MCF10A cells stably expressing Syn-GFP with the indicated depletions were treated with 90 nM MG132 for 3 h (Upper) or with 50 nM
MG132 for 5 h (Lower). (F) Depletion of LATS1 stimulates aggresome formation in response to proteasome inhibition. MCF10A cells stably expressing Syn-GFP
depleted of LATS1 were treated with 30 nM MG132 for 2.5 h.
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of LATS1/2 from these cells resulted in a remarkable up-regulation
of aggresome formation (SI Appendix, Fig. S4C). Importantly, ex-
pression of the siRNA-resistant form of LATS1 reversed the
aggresome-stimulating effect of LATS1/2 depletion (SI Appendix,
Fig. S4D). The observed effect of LATS1/2 depletion on aggresome
formation was temporary, and ultimately most of the MG132-treated
control cells formed aggresomes. Of note, we observed that an ac-
celeration of aggresome formation in MCF10A cells was seen with
siRNAs against LATS1, while siRNA against LATS2 had little effect
on the aggresome (SI Appendix, Fig. S4E). We verified that aggre-
some formation triggered by other DRiP-generating conditions is
also regulated by LATS1/2. Indeed, we observed significant accel-
eration of AZC-induced aggresome formation in cells depleted
of LATS1 (SI Appendix, Fig. S4C). Therefore, suppression of
LATS1 activity via the HB complex upon the buildup of ab-
normal polypeptides accelerates the aggresome response.
Hsp70–Bag3–LATS1 Signaling Regulates Early Events in Protein
Aggregation. If the sole function of Bag3 is promoting the
transport of aggregates to the aggresome, depletion of this
protein should cause the accumulation in the cytoplasm of
multiple aggregates that cannot be transported to the aggresome.
However, Bag3 depletion, while significantly decreasing the
number and size of aggresomes, did not increase the number of
visible aggregates in the cells (SI Appendix, Fig. S4B), suggesting
that Bag3 controls the formation of aggregates in addition to, or
rather than, their transport to aggresome. Therefore, we further
assessed the effects of Bag3 as well as of LATS1 on aggregate
formation. MCF10A control cells and cells depleted of these
proteins were incubated with MG132 or were left untreated, and
the aggregate fractions in preclarified lysates were separated by
centrifugation at 16,000 × g for 15 min. The samples were ana-
lyzed by immunoblot with anti-GFP antibody to detect Syn-GFP
(Fig. 5A) and with anti-ubiquitin antibody to detect ubiquitinated
polypeptides representing endogenous defective and short-lived
proteins. Upon proteasome inhibition, more Syn-GFP as well as
the ubiquitinated species could be seen in the insoluble fraction (for
Ponceau S-stained membranes see SI Appendix, Fig. S5A). However,
the addition of the translation inhibitor emetine obliterated this re-
distribution (Fig. 5A), suggesting that the aggregation of Syn-GFP
and ubiquitinated polypeptides is prompted by the accumulation
of DRiPs.
In agreement with the proposed role of Bag3 in protein ag-
gregation, its depletion significantly reduced amounts of both
Syn-GFP and ubiquitinated species associated with the insoluble
fraction (Fig. 5A). Furthermore, in line with the inhibitory role of
LATS1 in aggresome formation, depletion of this kinase pro-
moted the redistribution of these proteins into the particulate
fraction (Fig. 5A). Of note, we observed similar effects of Bag3 and
LATS1 on the distribution of Syn-GFP and of ubiquitinated species
to the low-speed centrifugation pellets (200 × g) used to clarify the
lysates and representing larger aggregates (SI Appendix, Fig. S5B).
Overall, these data indicate that the HB complex regulates LATS1
kinase to control the early stages of aggregate formation before
their transport to the aggresome.
To verify these conclusions, we monitored the effects of
Bag3 and LATS1 depletions on synphilin 1 aggregation microscopi-
cally. First, we examined these effects in nocodazole-treated cells, in
which Syn-GFP aggregates emerged upon MG132 treatment but
could not be transported to the aggresome. Depletion of Bag3 sig-
nificantly decreased the number of fluorescent aggregates (SI
Appendix, Fig. S5C, Upper), while depletion of LATS1 boosted the
aggregation (SI Appendix, Fig. S5C, Lower).
To better understand HB complex regulation of protein aggre-
gation, we utilized superresolution imaging by photoactivation lo-
calization microscopy (PALM) to resolve early stages of aggregate
formation that are undetectable using conventional fluorescence
microscopy. In these experiments, we replaced GFP on the C ter-
minus of synphilin 1 with photo-convertible Dendra-2 (Syn-DEN).
MCF10A cells stably expressing Syn-DEN were fixed, and the lo-
calization of Syn-DEN molecules was imaged. PALM images were
constructed by stacking up to 10,000 single frames, each collected
with a low-intensity excitation. To quantify the population of ag-
gregates and to study their evolution under the experimental con-
ditions, we developed a computational image-analysis code that
would scan the PALM imaging-generated localization maps (local-
ization of the Syn-DEN fluorophore emissions) using an image-
analysis algorithm DBSCAN (density-based spatial clustering of
applications with noise) (https://www.biorxiv.org/content/early/2017/
06/09/148395). On the localization maps DBSCAN grouped the
points with high local density of emission events into clusters (lo-
calizations) while eliminating outlier points that were surrounded by
fewer neighbors and thus represented monomers. This method al-
lows the identification of clusters containing as few as four or five
Syn-DEN molecules, allowing monitoring of early events in protein
aggregation (28) (https://www.biorxiv.org/content/early/2017/06/09/
148395). An example of the clusters found by DBSCAN in a typical
Syn-DEN localization map is shown in SI Appendix, Fig. S5D. In
addition to the small clusters below subdiffraction limits (invisible by
conventional microscopy), the superresolution localization map
allowed us to observe conventionally visible aggregates and aggre-
somes (SI Appendix, Fig. S5E). We found that treatment with
MG132 led to a significant shift in the distribution curve of Syn-
DEN cluster sizes at this scale (black vs. red curves in Fig. 5B),
indicating intensification of cluster growth. Depletion of Bag3 did
not affect cluster distribution in untreated cells (black and blue
curves in Fig. 5B). On the other hand, in cells depleted of Bag3 we
did not observe any cluster growth in the course of 2-h incubation
with MG132 (blue vs. green curves in Fig. 5B). Therefore, cluster
growth triggered by proteasome inhibition depends on Bag3 even at
the smallest size tier.
We further tested the effects of LATS1, another element of
the signaling machinery. In line with the biochemical and con-
ventional microscopy data, depletion of this kinase led to sig-
nificantly increased cluster sizes compared with the control cells
(Fig. 5C), indicating that this protein represses the early stages of
protein aggregation.
In a related study, cluster distribution analysis allowed us to
establish that the kinetics of protein aggregation is similar to
vapor condensation, where the system is in the supersaturated
state even in naive cells (29). This finding, in turn, allowed
establishing a critical cluster size below which clusters sponta-
neously dissolve but above which clusters spontaneously grow.
Changes in critical cluster size reflect changes in the concen-
tration of aggregating monomers and changes in the energy of
interactions between monomers. Mathematical analysis of ex-
periments in Fig. 5 B and C indicated that MG132 treatment
reduces the critical size and that Bag3 depletion prevents this
effect (SI Appendix, Fig. S5F). On the other hand, depletion of
LATS1 reduced the critical size even in naive cells. Given that
neither Bag3 nor LATS1 depletion significantly affected total
levels of synphilin or ubiquitinated species (Fig. 5A), the effects
on cluster critical size strongly suggest that these mutations
regulate the energy of the interaction between the aggregating
species. In other words, Bag3 is necessary for MG132-dependent
stimulation of the interaction between the monomers, and
LATS1 activity reduces this interaction.
Collectively, these data and the regulation of LATS1/2 by the
HB complex described above imply that in response to proteotoxic
stresses this system allows the initial stages of protein aggregation,
which eventually leads to aggresome formation (Fig. 5D).
Discussion
Previously, we reported that disruption of the HB complex either
genetically or pharmacologically dramatically affected multiple
signaling pathways involved in cancer development, which suggested
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that the HB complex has an important function in cell signaling.
In this work, we hypothesized that the HB module serves a
general role in detecting protein abnormalities following pro-
teasome inhibition and transmits signals to signaling kinases.
Indeed, we found that LATS kinases are regulated by protea-
some inhibition, and we present multiple lines of evidence in-
dicating that the HB complex plays an important role in this
signal-transduction process. Similarly, this complex mediated the
response of stress kinases to proteasome inhibition. Therefore,
the HB complex may play a general role in the cellular response
to an upsurge of abnormal polypeptides.
The buildup of abnormal proteins upon proteasome inhibition
depends mostly on defective polypeptides constantly generated
by the ribosome. Accordingly, AZC, which increases the gener-
ation of such proteins, stimulated the LATS1/2 response. On the
other hand, translation elongation inhibitors, which at low con-
centrations improve the quality of ribosomes’ output (17),
blocked the LATS1/2 response. Here we observed the direct
interaction of the HB complex with DRiPs. Indeed, in a
Bag3 pull-down we saw both newly translated ubiquitinated
species and radioactive species labeled during a short pulse.
Furthermore, proteasome inhibition, which blocks the degrada-
tion of DRiPs, increased their association with Bag3, while a
“chase” with unlabeled amino acids decreased this association.
The association of DRiPs with the HB complex was dependent
on Hsp70, which most likely recruits them to Bag3, since dis-
ruption of the Bag3 interaction with Hsp70 significantly reduced
the association. Notably, only a small fraction of DRiPs was
found in the complex with Bag3, which is an expected result
based on our mechanistic knowledge of the interaction of
Bag3 and Hsp70. Indeed, Bag3 interacts with Hsp70 only in its
ATP-bound form, i.e., in the open conformation, when poly-
peptides rapidly associate with Hsp70 and rapidly dissociate from
it. Therefore, the association of the HB complex with DRiPs
must be very dynamic, and at any moment only a fraction of
DRiPs would be in the complex.
A surprising finding here was that in the absence of additional
challenges, for example AZC, stalled polypeptides represent a
pool of abnormal ribosomal products which are preferentially
involved in sensing the proteasome failure by the HB complex.
Indeed, depletion of the ribosome-associated ubiquitin ligase
LTN1 or the chaperone VCP, which are responsible for the
Fig. 5. Bag3 and LATS1 regulate protein aggregation in response to proteasome inhibition. (A) Depletion of Bag3 reduces and depletion of LATS1 increases
the association of Syn-GFP and ubiquitinated species with the particulate fraction. MCF10A cells stably expressing Syn-GFP with the indicated depletions were
treated for 2 h with 2.5 μMMG132 with or without 0.5 μM emetine. The preclarified lysates were subjected to 15-min centrifugation at 16,000 × g. The pellets
were washed once with a lysis buffer and then were dissolved in Laemmli sample buffer for immunoblotting with the antibodies indicated on the left. Note
that both bands developed with anti-GFP antibody are specific. (B) The effects of incubation with 1 μMMG132 on the distribution of cluster sizes in naive and
Bag3-depleted cells. Survival plots delineate a fraction of clusters containing at least N (indicated on the x axis) localization counts. Each plot was generated
from 10 cells and represents the statistical distribution of 9,000–10,000 identified aggregates. (C) Survival plot showing the effects of LATS1 depletion on the
distribution of cluster sizes in naive cells. Each plot was generated from 10 cells and represents the statistical distribution of 4,000 (LATS1) or 7,000 (control)
identified aggregates. (D) A model for DRiPs sensing by the HB complex. Blue indicates elements of the pathway regulating the aggregation response. Red
indicates changes upon proteasome inhibition; under these conditions the HB complex suppresses LATS1/2, thus removing its inhibition of protein aggregation.
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ubiquitination and release of nonstop and stalled polypeptides
from the ribosome, reduced the response to proteasome in-
hibition. These data are in line with previous reports that Paget
disease-related mutations in VCP suppress aggresome formation
(30) and that a temperature-sensitive mutation in the VCP
ortholog Cdc48 blocks the formation of aggresome-like struc-
tures in yeast (31). Together these findings suggest that the
HB-mediated sensing system is tuned to monitor not only pro-
teasome activity but also the fidelity of translation. Therefore,
the HB complex appears to serve a very general role in moni-
toring major physiological processes in the cell. Interestingly, the
finding of the role of HB complex in sensing DRiPs is com-
plemented by a recent report that this module plays a role in
targeting puromycil polypeptides for degradation (32).
Here we also report that NAC plays a role in sensing pro-
teotoxicity. Depletion of NAC elements significantly reduced the
association of a model stalled polypeptide with the HB complex
and suppressed both the regulation of LATS1/2 upon inhibition
of the proteasome and aggresome formation, suggesting that
NAC facilitates the association of stalled polypeptides with the
HB complex. Interestingly, structural studies identified the site
of NAC interaction with the ribosome in close proximity to a
location of the LTN1 domain responsible for the interaction with
polypeptides emerging from the large subunit pore (33, 34). It is
possible that NAC may cooperate with LTN1 in the ubiquiti-
nation of nonstop and stalled polypeptides and their release.
Overall, our model is that normally stalled polypeptides are
ubiquitinated by LTN1 and released and delivered to protea-
some for degradation. However, upon proteasome inhibition
they interact with the HB complex in an NAC-dependent man-
ner. The interaction of these polypeptides with the HB complex
modulates the activities of various associated kinases and pos-
sibly other signaling factors.
It should be noted that the HB complex may be able to detect
a variety of protein abnormalities that are not necessarily DRiPs.
In fact, this complex was reported to be involved in mechano-
transduction by sensing denatured filamin A (13).
The ability to sense a decline in proteasome activity has an
important physiological meaning. In aging or certain protein
conformation diseases the proteasome is down-regulated, and
cells activate protective responses or trigger apoptosis. Some of
the protective responses, e.g., induction of the genes encoding
proteasome proteins, involve stabilization and the accumulation
of a specific regulator, NRF2. However, the regulation of other
responses, including apoptosis, involves the activation of JNK (2)
and therefore is mediated by the HB complex. Similarly, acti-
vation of the protective aggresome response involves LATS1 and
is also mediated by the HB complex. Therefore, the HB complex
is involved in multiple processes that allow cells to adjust to
proteotoxic conditions.
The accepted paradigm for the role of Hsp70 and Bag3 in the
processes of aggresome formation is that Bag3 recruits Hsp70-
bound protein aggregates and links them to the dynein motor
complex that in turn drives the microtubule-dependent trans-
port. Here we show that signaling of the HB complex via
LATS1 plays a significant role in aggresome formation. Notably,
regulation of YAP or any other transcription factor by LATS1/
2 is not critical for the response, since the transcription inhibitor
actinomycin D does not inhibit the process (17). Therefore, in
regulating aggresome formation, LATS1 must control a different
target that is not a transcription factor.
An unexpected discovery here was that aggresome formation
could be regulated at the level of initial protein aggregation. The
concept that protein aggregation is controlled by signaling
pathways is counterintuitive, but here we identified signaling
elements that regulate this process.
The data obtained with PALMmicroscopy provided important
mechanistic insights into the early events leading to the appearance
of aggregates undetectable with conventional fluorescence micros-
copy. Using this methodology, we demonstrate that proteasome
inhibition facilitates the formation and growth of clusters compris-
ing only several Syn-DEN molecules. Importantly, depletion of
Bag3 blocked the effects of MG132 on the cluster size, while de-
pletion of LATS1 mimicked effects of proteasome inhibition in
untreated cells. The data obtained below subdiffraction limits were
in line with the effects of Bag3 and LATS1 depletion on the dis-
tribution of synphilin 1 and ubiquitinated polypeptides into the
particulate fractions measured biochemically. Given that neither
Bag3 nor LATS1 depletion affected the overall levels of these
species in the cell (Fig. 5A, Left), these data suggest that the HB–
LATS1 complex signals to enhance the strength of the interaction
between monomers and the forming aggregates. The simplest
possibility is that LATS1 phosphorylates either aggregating species
or a factor(s) that mediates their interactions. Overall, these data
indicate that the Hsp70–Bag3–LATS1 system transmits the signal of
proteasome inhibition to trigger protein aggregation.
Materials and Methods
Reagents and Antibodies. MG132 and nocodazole were purchased from
Biomol, emetine and AZC were purchased from Sigma-Aldrich, and 16%
formaldehyde was purchased from Thermo Scientific. YM-1 was developed
and supplied by Jason Gestwicki, University of California, San Francisco.
Antibodies against YAP, phospho-YAP (S127), phospho-JNK, phospho-p38,
anti-LATS1, and β-actin were from Cell Signaling Technology; anti-HspA1,
anti-HspA8, and anti-multiubiquitin (FK2) were from Enzo Life Sciences;
anti-BAG3 and anti-puromycin were from Millipore; anti-GFP (peptide) used
for immunoblotting was from Clontech; anti-GFP (full protein) used in the
Duolink assay (Sigma-Aldrich) and the modified ActivSignal assay was from
GeneTex; anti-FLAG (M2) was from Sigma-Aldrich; anti–V5-tag was from
Thermo Fisher Scientific (Pierce); anti-NACB was from Santa Cruz Bio-
technology; and anti-DNAJC2 was from Abgent.
Constructs and Oligonucleotides. The retroviral expression construct with C-
terminally tagged synphilin 1 (Syn-GFP) subcloned into the pCXbsr vector
was described previously (27). For PALM imaging EGFP at the C terminus of
the construct was replaced by Dendra-2. pcDNA3.1-based plasmids used for
overexpression of N-terminally FLAG-tagged Bag3 or its ΔC, ΔP, and ΔW
deletion mutants were described previously (6). Additionally, we constructed
a ΔM mutant missing a stretch between amino acids 86–214. For expression
in MCF10A cells, we cloned some of these constructs in retroviral vector
pBabe (puro). For pull-down experiments we replaced FLAG on the N ter-
minus of these constructs with the four following sequences connected by
short linkers: FLAG-tag, S-tag, SBP-tag, and (His)9-tag. To generate the GFP-
NS construct, we deleted the stop codon of the EGFP gene in pEGFP-
N1 plasmid and with small deletions and frame shifts eliminated any
in-frame stop codons in the flanking downstream sequence of about 200 bp
while preserving the downstream polyadenylation signals. For a reporter of
NACA association with Bag3, we synthesized and cloned in pcDNA3.1(+) a
gene encoding V5–FLAG–NACa1-b.
The retroviral Hsf1 shRNA construct and control vector were described
previously (35). We used the following siGENOME siRNAs purchased from
Dharmacon: nontargeting siRNA no. 5, BAG3 (D-011957-01), NACB (D-016634-
02), HSPA8 (M-017609-01), LTN1 (M-006968-00), VCP (M-008727-01), LATS2 (M-
003865-02), and DNAJC2 (M-025435-02). LATS1 (SASI_Hs01_00046130) and NACA
(SASI_Hs02_00325613) were purchased from Sigma. For the rescue of Bag3 de-
pletion by its overexpression, we synthesized siRNA homologous to the Bag3
shRNA, which was described previously (6) and to which the exogenous Bag3
constructs are resistant.
Cell Culture. HeLa (cervix carcinoma) cells were grown in DMEM supple-
mented with 10% FBS, and MCF10A (human breast epithelial) cells were
grown in DMEM/F-12 50/50 medium supplemented with 5% horse serum,
20 ng/mL epidermal growth factor, 0.5 μg/mL hydrocortisone, 10 μg/mL
human insulin, and 100 ng/mL cholera toxin. All cultures were supplemented
with L-glutamine as well as with MycoZap Plus-CL (Lonza) (for HeLa cells) or
Plasmocin (InvivoGen), penicillin, and streptomycin (for MCF10A cells), and
were grown at 37 °C with 5% CO2. For analysis with a fluorescence micro-
scope, cells were grown on Nunc Lab-Tek chambered cover glasses (Thermo
Fisher Scientific) pretreated with poly-L-lysine (Sigma).
For transient plasmid transfection of HeLa cells with Lipofectamine
2000 reagent (Invitrogen, Thermo Fisher Scientific), we followed the
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manufacturer’s protocol. In a 35-mm dish, 10 μL of the reagent were mixed
with 3 μg of plasmid(s). Cells were transfected for 2 h. One hour after the
end of transfection the cells were plated for an experiment conducted the
next day. For siRNA transfection, we used Lipofectamine RNAiMAX (Invi-
trogen, Thermo Fisher Scientific) and followed the manufacturer’s reverse-
transfection protocol. In a well on a 24-well plate, we mixed 0.4 μL of the
reagent with 2 μL of 10 μM siRNA in 100 μL of OptiMEM and added the
mixture to 400 μL of a cell suspension in the well. Twenty-four to twenty-
eight hours later the transfection was stopped, and the cells were plated for
an experiment conducted the next day.
Duolink Assay. The transfected HeLa cells were grown, treated with MG132,
fixed with 4% formaldehyde, and permeabilized with 0.2% Triton X-100 on a
Corning 96-Well Half-Area High-Content Imaging Glass Bottom Microplate.
We followed the manufacturer’s protocol using Duolink In Situ Detection
Reagent Red, Duolink In Situ PLA Probe Anti-Mouse PLUS, and Duolink In
Situ PLA Probe Anti-Rabbit MINUS purchased from Sigma-Aldrich. The pri-
mary antibodies used were anti-GFP and anti-FLAG antibodies raised in
rabbit and mouse, respectively. The resulting images were obtained with a
fluorescence microscope with a 20× objective from at least 10 blindly chosen
fields with a total at least 250 cells. We measured the combined fluorescence
of all cells with the NIH ImageJ program and normalized it by the number of
all counted cells stained with DAPI. In the images presented in SI Appendix,
Fig. S3, we chose an exposure time that provided visible red fluorescence in
less than 5% of the cells in control samples.
The PLA Based on a Modified ActivSignal Protocol. Transfected HeLa cells were
grown, treated with MG132, fixed with 4% formaldehyde, and permeabilized
with 0.2% Triton X-100 on a 96-well plastic plate. The samples were left in
buffer B (ActivSignal) at 4 °C overnight. All the following steps were conducted
at room temperature. The samples were incubated for 2 h with a pair of pri-
mary antibodies diluted in buffer B. After three washes with PBS and Tween-
20 (PBST), consecutive 1-h incubations in buffer B with each of the secondary
antibodies were done. After two washes with PBST followed by two washes
with TE buffer (10 mM Tris-HCl, 1 mM EDTA), a ligation mixture including a
linker oligo (50 nM) and T4 DNA ligase (5 U/mL) was added to the wells, and
the reaction was conducted for 30 min. The wells were washed once with PBST
and twice with TE, 50 μL of TE were added to each well, and the ligated
conjugates were extracted by 30-min incubation of the plate at 95 °C. The
eluates were assessed by qPCR using All-in-One qPCR Mix (GeneCopoeia)
according to the manufacturer’s protocol.
Donkey anti-rabbit (711-005-152) and donkey anti-mouse (715-005-150)
secondary antibodies were purchased from Jackson ImmunoResearch, Inc.
and were conjugated with a pair of oligonucleotides by ActivSignal, Inc. The
linker for the ligation reaction was provided by ActivSignal, Inc.
Total RNA Preparation and qRT-PCR. Total RNAs from cells were isolated using
the RNeasyMini Kit (Qiagen) andwere reverse transcribedwith SuperScript IV
VILO Master Mix with ezDNase Enzyme (Invitrogen, Thermo Fisher Scientific)
following the manufacturer’s instructions. qRT-PCR was performed using All-
in-One qPCR Mix (GeneCopoeia).
Conditions for cell lysis, immunoprecipitation, pull-down analysis, radio-
labeling, mass spectroscopy, and microscopy are described in SI Appendix.
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